Desmond Tutu HIV Foundation
|This article relies on references to primary sources. (December 2010)|
|This article needs additional citations for verification. (December 2010)|
The Desmond Tutu HIV Foundation (DTHF) is a nonprofit organization founded to provide treatment for and conduct HIV/AIDS research. It is based in Cape Town, South Africa and is managed with the Desmond Tutu HIV Centre at the University of Cape Town. The Foundation operates community sites throughout greater Cape Town, providing treatment, testing, and outreach services to at-risk communities. 
The Desmond Tutu HIV Foundation began as the HIV Research Unit based in New Somerset Hospital in the early 1990s. It was acclaimed as one of the first public clinics to offer anti-retroviral therapy to those living with HIV.
The Desmond Tutu HIV Foundation (DTHF) founded by Robin Wood and Linda-Gail Bekker in January 2004. It is supported by Desmond Tutu in its mission to include HIV and tuberculosis treatment, prevention, and training to the most affected populations in the South Africa and beyond. The DTHF has built a reputation for excellence in medical research and innovative community participation and support by working with local and international partners and with City and Provincial health authorities in the Western Cape. The foundation receives funding from PePFAR (President’s Emergency Plan for AIDS Relief) DAIDS (Division of Acquired Immunodeficiency Syndrome), the French Development Agency, Bill & Melinda Gates Foundation, and International AIDS Vaccine Initiative, among others.
The DTHF's projects include support programs for HIV positive youth, distance-learning training manuals and education, clinical support by HIV positive counselors, outreach to vulnerable groups such as men who have sex with men, holistic youth services including a youth center building in Masiphumelele, women’s health services, a children’s anti-retroviral clinic, and two colorful mobile HIV testing units called Tutu Testers. The DTHF has set up adult and youth community advisory boards to assist in building relationships with communities and increasing their understanding of the studies the DTHF undertakes its sites.
The foundation organized South African participantion for the IPrEx study, which was a clinical trial testing the effects of Truvada, a pre-exposure prophylaxis for HIV infection. The IPrEx study recruited participants from six countries— Brazil, Ecuador, Peru, South Africa, Thailand and the United States — partnering with the Desmond Tutu HIV Foundation for recruitment in South Africa.
In 2009 South Africa received R3.5-billion in development contracts from France as foreign aid, of which 3.3 million went to the DTHF.
- "History". Desmond Tutu HIV Foundation. Retrieved 10 December 2010.
- Brendan Boyle (29 Nov 2009). "SA receives most of France's Africa aid". Times LIVE. Retrieved 10 December 2010.